The R420Q mutation was first described in AML and was shown to inhibit Flt3 internalization and ubiquitination, leading to ligand-independent signaling of Flt3, which is able to transform myeloid cells in vitro (Sargin et al. 2007). This evidence concerns the gene FLT3 and acute myeloid leukemia.